These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10707445)
21. [Evaluation of 2 tuberculosis chemoprophylaxis regimens in patients infected with human immunodeficiency virus. The GECMEI Group]. Martínez Alfaro EM; Cuadra F; Solera J; Maciá MA; Geijo P; Sánchez Martínez PA; Rodríguez Zapata M; Largo J; Sepúlveda MA; Rosa C; Sánchez L; Espinosa A; Mateos F; Blanch JJ Med Clin (Barc); 2000 Jul; 115(5):161-5. PubMed ID: 10996870 [TBL] [Abstract][Full Text] [Related]
22. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Chaisson RE; Barnes GL; Hackman J; Watkinson L; Kimbrough L; Metha S; Cavalcante S; Moore RD Am J Med; 2001 Jun; 110(8):610-5. PubMed ID: 11382368 [TBL] [Abstract][Full Text] [Related]
23. Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates. Simkins J; Abbo LM; Camargo JF; Rosa R; Morris MI Transplantation; 2017 Jun; 101(6):1468-1472. PubMed ID: 27548035 [TBL] [Abstract][Full Text] [Related]
24. Underutilization of isoniazid chemoprophylaxis in tuberculosis contacts 50 years of age and older. A prospective analysis. Sorresso DJ; Mehta JB; Harvill LM; Bentley S Chest; 1995 Sep; 108(3):706-11. PubMed ID: 7656620 [TBL] [Abstract][Full Text] [Related]
25. User views on supervised methadone consumption. Stone E; Fletcher K Addict Biol; 2003 Mar; 8(1):45-8. PubMed ID: 12745415 [TBL] [Abstract][Full Text] [Related]
26. Operational assessment of isoniazid prophylaxis in a community AIDS service organisation in Uganda. Lugada ES; Watera C; Nakiyingi J; Elliott A; Brink A; Nanyunja M; French N; Antivelink L; Gilks C; Whitworth J Int J Tuberc Lung Dis; 2002 Apr; 6(4):326-31. PubMed ID: 11936742 [TBL] [Abstract][Full Text] [Related]
27. INH preventive therapy among adult HIV-infected patients in Thailand. Hiransuthikul N; Nelson KE; Hiransuthikul P; Vorayingyong A; Paewplot R Int J Tuberc Lung Dis; 2005 Mar; 9(3):270-5. PubMed ID: 15786889 [TBL] [Abstract][Full Text] [Related]
28. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review. Bell J; Mutch C Drug Alcohol Rev; 2006 Mar; 25(2):167-71. PubMed ID: 16627307 [TBL] [Abstract][Full Text] [Related]
29. New methadone formulation in France: results from 5 years of utilization. Boucherie Q; Frauger E; Thirion X; Mallaret M; Micallef J Therapie; 2015; 70(2):223-34. PubMed ID: 25858579 [TBL] [Abstract][Full Text] [Related]
30. Characteristics of infants exposed to maternal tuberculosis and chemoprophylaxis using 3 months of isoniazid and rifampicin. Mathivha KT; Velaphi S Paediatr Int Child Health; 2017 May; 37(2):129-134. PubMed ID: 27455907 [TBL] [Abstract][Full Text] [Related]
31. [Evaluation of compliance with antituberculous chemoprophylaxis among recluse population of the Jaen penitentiary center]. Romero Saldaña M; Vaquero Abellán M; Gallego Rubio R; Aguilera López MD; de Celis Cornejo JM; Barquín García E; Zurita Serrano R Rev Esp Salud Publica; 1997; 71(4):391-9. PubMed ID: 9490193 [TBL] [Abstract][Full Text] [Related]
32. Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance. Reves R; Heilig CM; Tapy JM; Bozeman L; Kyle RP; Hamilton CD; Bock N; Narita M; Wing D; Hershfield E; Goldberg SV; Int J Tuberc Lung Dis; 2014 May; 18(5):571-80. PubMed ID: 24903795 [TBL] [Abstract][Full Text] [Related]
33. [Active tuberculosis in children who received INH chemoprophylaxis]. Ikeda K; Sugimori M; Kawasaki K; Kurokawa H; Kijimoto C Kekkaku; 1992 Oct; 67(10):653-8. PubMed ID: 1453566 [TBL] [Abstract][Full Text] [Related]
34. Isoniazid Resistance and Dosage as Treatment for Patients with Tuberculosis. Nagel S; Streicher EM; Klopper M; Warren RM; Van Helden PD Curr Drug Metab; 2017; 18(11):1030-1039. PubMed ID: 29086682 [TBL] [Abstract][Full Text] [Related]
35. Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients. Kimerling ME; Phillips P; Patterson P; Hall M; Robinson CA; Dunlap NE Chest; 1998 May; 113(5):1178-83. PubMed ID: 9596291 [TBL] [Abstract][Full Text] [Related]
36. A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis. Jung JA; Kim TE; Lee H; Jeong BH; Park HY; Jeon K; Kwon OJ; Ko JW; Choi R; Woo HI; Koh WJ; Lee SY Drug Des Devel Ther; 2015; 9():5433-8. PubMed ID: 26491254 [TBL] [Abstract][Full Text] [Related]
37. Models for treating tuberculosis in narcotic-addicted patients. Newman RG; DesJarlais DC J Subst Abuse Treat; 1994; 11(1):61-2. PubMed ID: 8201635 [No Abstract] [Full Text] [Related]
38. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. Strain EC; Bigelow GE; Liebson IA; Stitzer ML JAMA; 1999 Mar; 281(11):1000-5. PubMed ID: 10086434 [TBL] [Abstract][Full Text] [Related]
39. Is isoniazid safe for liver transplant candidates with latent tuberculosis? Stucchi RS; Boin IF; Angerami RN; Zanaga L; Ataide EC; Udo EY Transplant Proc; 2012 Oct; 44(8):2406-10. PubMed ID: 23026607 [TBL] [Abstract][Full Text] [Related]
40. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases. Sneag DB; Schaaf HS; Cotton MF; Zar HJ Pediatr Infect Dis J; 2007 Dec; 26(12):1142-6. PubMed ID: 18043453 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]